Myocene

Myocene is a Belgian sports technology company based in Liège that has developed a revolutionary device for measuring muscle fatigue in athletes. The company's patented technology uses a combination of electrostimulation, force sensors, and algorithmic analysis to provide an objective and quantifiable measurement of an individual's muscle fatigue index in just two minutes. The Myocene device represents a significant breakthrough in the sports world, enabling elite athletes and coaches to better monitor and manage fatigue levels, optimize training programs, prevent overtraining, and reduce the risk of injuries related to long-term muscular fatigue.

The Myocene device has been scientifically validated for its reliability and consistency in measuring muscle fatigue. In April 2023, a study published in the peer-reviewed journal Frontiers in Physiology confirmed the device's validity as a tool for assessing long-term fatigue and monitoring muscle fatigability in athletes. The company had signed contracts with several elite European sports clubs, including OGC Nice, RC Strasbourg, Sporting Clube de Braga, and Paris-Saint Germain, to provide its cutting-edge technology for optimizing player performance.

In February 2024, Myocene obtained the ISO 13485 certification for its quality management system, demonstrating that its products are designed and manufactured according to the highest standards of quality. This certification also paves the way for the company to access the US market, as it aligns with the FDA's Good Manufacturing Practice requirements.

Myocene's technology has been embraced by the scientific community and is regularly used in research studies at various universities across Europe, including Poitiers, Montpellier, Burgundy, Savoie Mont-Blanc (France), HES-SO (Switzerland), Ruhr University Bochum (Germany), and the University of Salzburg (Austria). In June 2024, the company raised EUR 3 million to accelerate its international commercialization efforts in Europe and the US.